We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Feasibility Study on Ceramic Femoral Component

By HospiMedica staff writers
Posted on 19 Mar 2001
A ceramic femoral knee component used in total knee replacement is designed to avoid the problem of polymer wear, bone resorption, and subsequent implant loosening.

The ceramic component, from Encore Orthopedics, Inc. More...
(Austin, TX, USA; www.encoremed.com), is made from zirconia oxide by Saint Gobain Desmarquest (Evruex, France). The component has geometry similar to the cobalt-chromium alloy femoral component of Encore's Foundation Knee system. This allows it to be used in conjunction with the Foundation tibial and patellar components in treating patients with arthritis of the knee joint. Laboratory walking simulation at the University of Nebraska Medical Center (Lincoln, USA) has shown that the zirconia femur produces 250% less wear debris than traditional metal/polyethylene knee replacement devices.

A feasibility clinical study will involve three investigational sites and 21 implants, as a precursor to a full pivotal study involving 20 surgeons and 300-400 patients. "Laboratory and clinical data would support the position that the ceramic femoral component is an important step in developing a total knee prosthesis that will outlast the patient, regardless of age or activity level of the patient,” said J.D. Webb, vice president, research and development, for Encore Orthopedics.



Related Links:
Encore Orthopedics

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.